Efficacy and Safety of Vildagliptin as an Add-on to Insulin with or without Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A 12-week, Double-Blind, Randomized Study

INTRODUCTION: To assess the efficacy and safety of vildagliptin as add-on therapy in Japanese patients with type 2 diabetes mellitus (T2DM), inadequately controlled on stable long-acting, intermediate-acting, or pre-mixed insulin, with or without concomitant metformin. METHODS: In this 12-week place...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Diabetes Ther
Egile Nagusiak: Hirose, Takahisa, Suzuki, Manabu, Tsumiyama, Isao
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Healthcare 2015
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4674469/
https://ncbi.nlm.nih.gov/pubmed/26620049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-015-0147-6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak